Identification of natural compounds tubercidin and lycorine HCl against small‐cell lung cancer and BCAT1 as a therapeutic target

Although small‐cell lung cancer (SCLC) accounts for a small fraction of lung cancer cases (~15%), the prognosis of patients with SCLC is poor with an average overall survival period of a few months without treatment. Current treatments include standard chemotherapy, which has minimal efficacy and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jungang, Barrett, Lindsey, Lin, Zhen, Kendrick, Samantha, Mu, Shengyu, Dai, Lu, Qin, Zhiqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077304/
https://www.ncbi.nlm.nih.gov/pubmed/35318805
http://dx.doi.org/10.1111/jcmm.17246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077304/
https://www.ncbi.nlm.nih.gov/pubmed/35318805
http://dx.doi.org/10.1111/jcmm.17246

Ejemplares similares